Maridebart Cafraglutide
Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous Presentations After Multiple Doses
Amgen · Phase 1 · Not yet recruiting · Enrollment 356
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.